NEXT Oncology Barcelona IOB Hospital Quirónsalud

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody	Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasm, refractory malignant neoplasm	Active, not recruiting	Phase 1 / Phase 2	2025-02-04		NCT05662397

Clinical trials